Wellington Management Group’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Wellington Management Group’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-648,653	Closed	-$2.58M	–	2238
2022 Q1	$2.58M	Sell	648,653 -61,582	-9%	-$320K	﹤0.01%	1547
2021 Q4	$6.04M	Sell	710,235 -251,374	-26%	-$2.49M	﹤0.01%	1419
2021 Q3	$10.9M	Buy	961,609 +257,246	+37%	+$3.09M	﹤0.01%	1254
2021 Q2	$7.18M	Sell	704,363 -4,685	-0.7%	-$48.1K	﹤0.01%	1388
2021 Q1	$7.74M	Sell	709,048 -46,307	-6%	-$661K	﹤0.01%	1305
2020 Q4	$8.6M	Sell	755,355 -4,578	-0.6%	-$52.9K	﹤0.01%	1220
2020 Q3	$8.95M	Sell	759,933 -56,170	-7%	-$657K	﹤0.01%	1141
2020 Q2	$8.19M	Buy	+816,103	New	+$11.3M	﹤0.01%	1114

Other funds holding AYLA

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

DAM

DLD Asset Management New York $1.51B AUM 5.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group's AYLA Position: Q2 2022 in Review

Wellington Management Group sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q2 2022, closing a stake of 648,653 shares — an estimated $2.58M sold.

Wellington Management Group first reported a position in AYLA in Q2 2020 and held it in 8 quarters. The position peaked at $10.9M in Q3 2021. 15 funds tracked by Wall St. Rank hold AYLA as of Q2 2022.

Wellington Management Group reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Wellington Management Group sold 648,653 Ayala Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $2.58M.
Wellington Management Group first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
Wellington Management Group's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $10.9M in Q3 2021.
15 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Wellington Management Group's 13F filing for Q2 2022, filed 15 Aug 2022.